PeakData, a Zug, Switzerland-based provider of an AI customer targeting platform for pharmaceutical companies, raised €12.1m (CHF 12m) in Series A funding.
The round was led by AlbionVC with participation from Octopus Ventures and Heal Capital.
The company will use the funding to expand all aspects of the business to support their growth plans.
The brainchild of data scientists Patrick De Boer and Michael Feldman, PeakData provides an AI platform that identifies and collates the most relevant and impactful healthcare professionals (HCPs) for pharmaceutical companies. The solution enables pharmaceutical companies to uncover the whole therapeutic area by mapping the healthcare professionals (HCP’s) most relevant to their target market. This essential mapping of a wide range of relevant HCPs means patients benefit from innovative new medicines more quickly and receive better treatment.
The platform uses AI algorithms to rank these HCPs in terms of their digital impact, influence and relevance to their target market and uses dynamic data to observe changes in HCP status over time.
The platform is now being used by over half of Europe’s largest pharmaceutical companies.
The company has grown from 12 to 70 employees since 2021.
FinSMEs
22/08/2022